ARAY
Accuray IncorporatedNASDAQHEALTHCAREMEDICAL DEVICES
Key Statistics
Market Cap
$51.45M
P/E Ratio
—
EPS
$-0.31
Beta
1.32
52W High
$2.10
52W Low
$0.33
50-Day MA
$0.45
200-Day MA
$1.05
Dividend Yield
—
Profit Margin
-8.15%
Forward P/E
94.34
PEG Ratio
29.49
About Accuray Incorporated
Accuray Incorporated designs, develops and sells radiosurgery and radiation therapy systems for the treatment of tumors in the body in the Americas, Europe, the Middle East, India, Japan, Africa and the rest of the Asia Pacific region. The company is headquartered in Sunnyvale, California.
Fundamentals
| Revenue (TTM) | $436.97M |
| Gross Profit (TTM) | $121.69M |
| EBITDA | $-1.70M |
| Operating Margin | -5.37% |
| Return on Equity | -70.30% |
| Return on Assets | -1.18% |
| Revenue/Share (TTM) | $3.89 |
| Book Value | $0.45 |
| Price-to-Book | 0.99 |
| Price-to-Sales (TTM) | 0.12 |
| EV/Revenue | 0.425 |
| EV/EBITDA | 26.28 |
| Quarterly Earnings Growth (YoY) | -96.20% |
| Quarterly Revenue Growth (YoY) | -12.00% |
| Shares Outstanding | $118.78M |
| Float | $112.87M |
| % Insiders | 4.10% |
| % Institutions | 70.53% |
Historical Volatility
HV 10-Day
88.69%
HV 20-Day
113.67%
HV 30-Day
115.84%
HV 60-Day
111.21%
HV Rank
94.8%
Volatility is currently contracting
Analyst Ratings
Consensus ($2.52 target)
2
BuyData last updated: 4/29/2026